Current opinion in neurology · 2011
Vascular disorders in neuro-ophthalmology.
СтатьяПоддержка NIH: внешняя программаОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hayreh Sohan Singh
Аннотация
PURPOSE OF REVIEW: The aim is to briefly discuss the currently controversial management of nonarteritic anterior ischemic optic neuropathy (NA-AION) and central retinal artery occlusion (CRAO).
RECENT FINDINGS: The role of systemic corticosteroid therapy and aspirin in NA-AION and of thrombolysis in CRAO is discussed.
SUMMARY: NA-AION is a major cause of seriously impaired vision. A recent large prospective study has shown that systemic corticosteroid resulted in a significantly higher probability of improvement in visual acuity (P = 0.001) and visual fields (P = 0.005), compared to an untreated group. In CRAO, the latest prospective study has shown that thrombolytic therapy not only has no beneficial effect but also is harmful.
RECENT FINDINGS: The role of systemic corticosteroid therapy and aspirin in NA-AION and of thrombolysis in CRAO is discussed.
SUMMARY: NA-AION is a major cause of seriously impaired vision. A recent large prospective study has shown that systemic corticosteroid resulted in a significantly higher probability of improvement in visual acuity (P = 0.001) and visual fields (P = 0.005), compared to an untreated group. In CRAO, the latest prospective study has shown that thrombolytic therapy not only has no beneficial effect but also is harmful.